These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1231464)

  • 21. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equilibrium binding assay and kinetic characterization of insulin antibodies.
    Goldman J; Baldwin D; Pugh W; Rubenstein AH
    Diabetes; 1978 Jun; 27(6):653-60. PubMed ID: 658611
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 24. The immunogenicity of insulin preparations.
    Chance RE; Root MA; Galloway JA
    Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
    Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ
    Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic response to mono-component insulin in newly diagnosed diabetic patients.
    Devlin JG; Parameswaran V
    Ir Med J; 1975 Jun; 68(12):301-5. PubMed ID: 1140940
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin therapy in patients with systemic insulin allergy.
    Mattson JR; Patterson R; Roberts M
    Arch Intern Med; 1975 Jun; 135(6):818-21. PubMed ID: 1130927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High and low affinity insulin antibodies.
    Kerp L; Kasemir H
    Acta Endocrinol Suppl (Copenh); 1976; 205():211-22. PubMed ID: 1087091
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.
    Sakata S; Matsuda M; Komaki T; Miura K
    Immunol Invest; 1987 May; 16(3):263-71. PubMed ID: 3311984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.
    Goldman J; Baldwin D; Rubenstein AH; Klink DD; Blackard WG; Fisher LK; Roe TF; Schnure JJ
    J Clin Invest; 1979 May; 63(5):1050-9. PubMed ID: 447827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experiences with monocomponent insulin treatment].
    Korp W; Levett RE
    Wien Klin Wochenschr; 1973 May; 85(18):326-30. PubMed ID: 4699490
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes of insulin antibody binding ability during monocomponent insulin therapy].
    Araki S; Sasai T; Shichiri M; Yoshikawa R; Hoshi M
    Horumon To Rinsho; 1977 Jan; 25(1):55-60. PubMed ID: 557390
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunologic tolerance against insulin. A therapeutic goal to prevent immunological complications in the diabetic patient using insulin].
    Jansen FK
    Med Welt; 1972 Nov; 23(48):1818-9. PubMed ID: 4654716
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Considerations on the insulin-binding property of the blood of normal subjects and diabetics never treated with insulin].
    Lunetta M; Calcagno G; Motta L; Lombardo T
    Acta Diabetol Lat; 1968; 5(2):201-14. PubMed ID: 5724365
    [No Abstract]   [Full Text] [Related]  

  • 36. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-precipitating antibodies in insulin-treated and untreated diabetic patients.
    Penchev I; Andreev D; Ditzov S
    Diabetologia; 1968 Jun; 4(3):164-6. PubMed ID: 5738355
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of insulin antibodies on free and total plasma-insulin.
    Kurtz AB; Mustaffa BE; Daggett PR; Nabarro JD
    Lancet; 1977 Jul; 2(8028):56-8. PubMed ID: 69146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of immune complexes in insulin-treated diabetics.
    Jayarao KS; Faulk WP; Karam JH; Grodsky GM; Forsham PH
    J Immunol Methods; 1973 Dec; 3(4):337-45. PubMed ID: 4591347
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunoreactivity of insulin antibodies in insulin-treated diabetics: significance of the beta-chain carboxy-terminal amino acid (B-30) of insulin.
    Kumar D
    Diabetes; 1979 Nov; 28(11):994-1000. PubMed ID: 573716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.